Characteristics
|
Cases (n = 182)
|
Percentage (%)
|
---|
LAG-3 expression on TILs
|
High
|
147
|
80.8
|
Low
|
35
|
19.2
|
PD-1 expression on TILs
|
High
|
90
|
49.5
|
Low
|
92
|
50.5
|
PD-L1 expression on TC
|
High
|
39
|
21.4
|
Low
|
143
|
78.6
|
PD-L1 expression on TILs
|
High
|
154
|
84.6
|
Low
|
28
|
15.4
|
CD3+ TIL
|
High
|
125
|
68.7
|
Low
|
57
|
31.3
|
GZMB
|
High
|
44
|
24.2
|
Low
|
138
|
75.8
|
- LAG-3: lymphocyte activating 3; PD-L1: programmed death ligand 1; PD-1: programmed death 1; TIL: tumor-infiltrating lymphocyte; TC: tumor cell; GZMB: granzyme B; NSCLC: non-small cell lung cancer